Cargando…
Across-cancer specific immune responses induced by nanovaccines or microvaccines to prevent different cancers and cancer metastasis
Metastatic cancers and recurrent cancers are diverse, different from primary cancers, and organ-dependent. However, how strong are across-cancer immune responses among different types of cancers remain unclear. Herein, vaccines-encapsulated-whole-components-of-tumor-tissue (VEWCOTT) were applied to...
Autores principales: | Diao, Lu, Ma, Lin, Cheng, Junping, Pan, Yunzhi, Peng, Zuofu, Zhang, Lianjun, Xu, Minghao, Li, Yupei, Zhang, Xuenong, Jiang, Honglv, Xu, Guoqiang, Meng, Fenghua, Zhong, Zhiyuan, Liu, Mi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682363/ https://www.ncbi.nlm.nih.gov/pubmed/36437877 http://dx.doi.org/10.1016/j.isci.2022.105511 |
Ejemplares similares
-
Probiotics formulation and cancer nanovaccines show synergistic effect in immunotherapy and prevention of colon cancer
por: Xu, Xiangxiang, et al.
Publicado: (2023) -
Lipid Microparticles Show Similar Efficacy With Lipid Nanoparticles in Delivering mRNA and Preventing Cancer
por: Ji, Afang, et al.
Publicado: (2022) -
CpG-Based Nanovaccines for Cancer Immunotherapy
por: Chen, Wenqiang, et al.
Publicado: (2021) -
Self-adjuvanting cancer nanovaccines
por: Liao, Zhiyun, et al.
Publicado: (2022) -
In Situ Cocktail Nanovaccine for Cancer Immunotherapy
por: Liu, Mohan, et al.
Publicado: (2023)